微粒体
重组DNA
药理学
人肝
药品
微粒体
酶
抑制性突触后电位
药物相互作用
化学
非竞争性抑制
高效液相色谱法
生物化学
生物
内分泌学
色谱法
基因
作者
Peipei Miao,Yuanyuan Zhao,Qing Miao,Chang‐E Guo,Chen Hong-ying,Ning Chen,Yujie Zhang,Shuang‐Cheng Ma
出处
期刊:China journal of Chinese materia medica
[China Journal of Chinese Materia Medica]
日期:2016-02-01
标识
DOI:10.4268/cjcmm20160324
摘要
To predit the mechanism of metabolic drug-drug interactions of hydroxygenkwanin with other drugs, we investigated the inhibition inhibitory effect of hydroxygenkwanin on UGTs and UGT1A1 activities of different liver microsomes. In the present study, 4-nitrophenol (4-NP) and β-estradiol were elected as substrates to determine activities of UGTs and UGT1A1 by UV and HPLC, respectively. The results showed that, hydroxygenkwanin significantly inhibited UGTs activity in rat, mouse and human liver microsomes. UGT1A1 activity was inhibited by hydroxygenkwanin to varying degrees, with IC₅₀ about 190, 10.93, 20.07, 76.31 μmol•L⁻¹ in mouse liver microsome(MLM), rat liver microsome (RLM) and recombinant UGT1A1, and human liver microsome (HLM), respectively. The inhibition types were competitive inhibition (RLM, HLM) and linear mixed-typed linear inhibition (recombinant UGT1A1). The order for the inhibitory intensity was RLM>rUGT1A1>HLM>MLM. In conclusion, hydroxygenkwanin has an inhibitory effect on UGTs and UGT1A1 activities of different liver microsomes, with differences in species, indicating its potential drug interactions based on UGT1A1 enzyme. This study aims to provide a reliable experimental basis for its further research and development of hydroxygenkwanin, and provide theoretical reference for the clinic drug combination research.
科研通智能强力驱动
Strongly Powered by AbleSci AI